Skip to main content

Table 2 Baseline characteristics

From: Tailored nurse-led cardiac rehabilitation after myocardial infarction results in better risk factor control at one year compared to traditional care: a retrospective observational study

  Traditional care Tailored nurse-led care P-value
Number of patients: 105 112  
Demographics:
 • Men n = 57, 71% n = 83, 74% 0.67
 • Age, years 61.7 (±9.1) 61.8 (±8.0) 0.10
Risk factors:
 • Diabetes Mellitus n = 33, 31% n = 21, 19% 0.10
 • Active smoker n = 43, 41% n = 40, 36% 0.35
 • SBP, mmHg 149.9 (±32.2) 153.7 (±24.2) 0.33
 • DBP, mmHg 87.1 (±17.3) 87.4 (±15.2) 0.90
 • BMI, kg/m2 27.3 (±4.5) 27.9 (±4.5) 0.37
 • Total cholesterol, mmol/L 5.0 (±1.2) 4.6 (±1.0) 0.01
 • LDL, mmol/L 3.0 (±1.2) 2.7 (±0.9) 0.45
 • HDL, mmol/L 1.2 (±0.4) 1.2 (±0.4) 0.19
 • TG, mmol/L 1.8 (±1.3) 1.5 (±0.7) 0.07
LVEF at the time of index event
 • Normal (≥50%) n = 68, 65% n = 88, 79% 0.09
 • Mildly decreased (40–49%) n = 20, 19% n = 17, 15%
 • Moderately decreased (30–39%) n = 8, 8% n = 4, 4%
 • Severely decreased (≤29%) n = 3, 3% n = 0
History of cardiovascular disease:
 AMI, PCI or CABG n = 19, 18% n = 22, 20% 0.83
Type of myocardial infarction
 • NSTEMI n = 74, 70% n = 73, 65% 0.40
 • STEMI n = 31, 30% n = 38, 34% 0.49
Number of vessels affected
 • No significant stenosis n = 7, 16% n = 4, 10% 0.44
 • 1–2 affected vessels n = 23, 51% n = 27, 64%
 • 3 affected vessels or left main stenosis n = 15, 33% n = 11, 26%
In-hospital treatment:
 • PCI n = 81, 77% n = 85, 76% 0.62
 • CABG n = 12, 11% n = 20, 18% 0.25
Pharmacological treatment at hospital discharge:
 • Platelet inhibitors n = 105, 100% n = 111, 99% 0.33
 • Statins n = 104, 99% n = 110, 98% 0.97
 • Ezetimibe n = 1, 1% n = 1, 1% 0.62
 • ACEi or ARB n = 103, 98% n = 103, 92% 0.06
 • Β-blockers n = 91, 87% n = 96, 86% 0.62
  1. Numbers presented as numbers (n) and percentages (%) or means (±SD) and p-values for difference
  2. SBP systolic blood pressure, DBP diastolic blood pressure, BMI body mass index, LDL low density lipoprotein, HDL high density lipoprotein, TG triglycerides, LVEF left ventricular ejection fraction, PCI percutaneous coronary intervention, CABG coronary artery bypass grafting, NSTEMI non-ST elevation myocardial infarct, STEMI ST elevation myocardial infarct, ACEi angiotensin converting enzyme inhibitor, ARB angiotensin II receptor blocker